Tag: Aviragen Therapeutics

February 8, 2018

Aviragen and Vaxart Amend Terms of Merger Agreement

Aviragen Therapeutics (NASDAQ:AVIR) and Vaxart announced that the companies have agreed to amend the terms of their previously announced merger...
April 4, 2017

Aviragen Will Review Strategic Alternatives And Gives Update

Aviragen Therapeutics (NASDAQ:AVIR) announced a review of strategic alternatives and provided a corporate update on the future of the company.